Exploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
John Cho, MD, PhD, FRCPC
How ALK Vaccines Could Prolong TKI Response in mNSCLC
Angel Qin, MD
How Novel Strategies Could Push ALK+ mNSCLC Care Forward
Guiding mNSCLC Treatment After ALK-TKI Progression
Alice T. Shaw, MD, PhD
Investigating Unanswered Questions in ALK+ mNSCLC Care
Patterns of Progression and Resistance in ALK+ mNSCLC
CAR T-Cell vs Bispecific Therapies for R/R Multiple Myeloma: How They Compare
Charles Turck, PharmD, BCPS, BCCCP
Krina Patel, MD, MSc
A New Era of Hope in Non-Small Cell Lung Cancer Care
Geoffrey Oxnard, MD
The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Raghava Reddy Induru, MD
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Key Questions Shaping Antibody-Drug Conjugate Use in NSCLC
Laura Alder, MD
The Importance of Multidisciplinary Coordination in NSCLC Care
Innovations Shaping the Future of Antibody-Drug Conjugates in NSCLC
Christine Bestvina, MD
Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
Improving Adherence and Toxicity Monitoring in NSCLC Care
Moving Toward Biomarker-Driven Care in Bladder Cancer
Benjamin Garmezy, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.